These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Fighting the tuberculosis epidemic in the Western Pacific region: current situation and challenges ahead. van Maaren PJ Kekkaku; 2010 Jan; 85(1):9-16. PubMed ID: 20143671 [TBL] [Abstract][Full Text] [Related]
3. The risk of global epidemic replacement with drug-resistant Mycobacterium tuberculosis strains. McBryde ES; Meehan MT; Doan TN; Ragonnet R; Marais BJ; Guernier V; Trauer JM Int J Infect Dis; 2017 Mar; 56():14-20. PubMed ID: 28163165 [TBL] [Abstract][Full Text] [Related]
4. Multidrug resistant tuberculosis: prevalence and risk factors in districts of metema and west armachiho, Northwest Ethiopia. Mekonnen F; Tessema B; Moges F; Gelaw A; Eshetie S; Kumera G BMC Infect Dis; 2015 Oct; 15():461. PubMed ID: 26503269 [TBL] [Abstract][Full Text] [Related]
6. Epidemic levels of drug resistant tuberculosis (MDR and XDR-TB) in a high HIV prevalence setting in Khayelitsha, South Africa. Cox HS; McDermid C; Azevedo V; Muller O; Coetzee D; Simpson J; Barnard M; Coetzee G; van Cutsem G; Goemaere E PLoS One; 2010 Nov; 5(11):e13901. PubMed ID: 21085569 [TBL] [Abstract][Full Text] [Related]
7. Controlling multidrug-resistant tuberculosis and access to expensive drugs: a rational framework. Pablos-Mendez A; Gowda DK; Frieden TR Bull World Health Organ; 2002; 80(6):489-95; discussion 495-500. PubMed ID: 12132008 [TBL] [Abstract][Full Text] [Related]
8. Assessing the transmission risk of multidrug-resistant Mycobacterium tuberculosis epidemics in regions of Taiwan. Liao CM; Lin YJ Int J Infect Dis; 2012 Oct; 16(10):e739-47. PubMed ID: 22818291 [TBL] [Abstract][Full Text] [Related]
9. High rates of multidrug-resistant and rifampicin-resistant tuberculosis among re-treatment cases: where do they come from? Ragonnet R; Trauer JM; Denholm JT; Marais BJ; McBryde ES BMC Infect Dis; 2017 Jan; 17(1):36. PubMed ID: 28061832 [TBL] [Abstract][Full Text] [Related]
10. Cost-effectiveness of treating multidrug-resistant tuberculosis. Resch SC; Salomon JA; Murray M; Weinstein MC PLoS Med; 2006 Jul; 3(7):e241. PubMed ID: 16796403 [TBL] [Abstract][Full Text] [Related]
11. Management of difficult multidrug-resistant tuberculosis and extensively drug-resistant tuberculosis: update 2012. Chang KC; Yew WW Respirology; 2013 Jan; 18(1):8-21. PubMed ID: 22943408 [TBL] [Abstract][Full Text] [Related]
12. Multidrug resistant tuberculosis in Ethiopian settings and its association with previous history of anti-tuberculosis treatment: a systematic review and meta-analysis. Eshetie S; Gizachew M; Dagnew M; Kumera G; Woldie H; Ambaw F; Tessema B; Moges F BMC Infect Dis; 2017 Mar; 17(1):219. PubMed ID: 28320336 [TBL] [Abstract][Full Text] [Related]
13. Underestimated pyrazinamide resistance may compromise outcomes of pyrazinamide containing regimens for treatment of drug susceptible and multi-drug-resistant tuberculosis in Tanzania. Juma SP; Maro A; Pholwat S; Mpagama SG; Gratz J; Liyoyo A; Houpt ER; Kibiki GS; Mmbaga BT; Heysell SK BMC Infect Dis; 2019 Feb; 19(1):129. PubMed ID: 30732572 [TBL] [Abstract][Full Text] [Related]
14. [Multidrug-resistant tuberculosis: challenges of a global emergence]. Comolet T Bull Soc Pathol Exot; 2015 Oct; 108(4):290-8. PubMed ID: 26289547 [TBL] [Abstract][Full Text] [Related]
15. Treatment outcome of multidrug-resistant tuberculosis in Japan - the first cross-sectional study of Japan tuberculosis surveillance data. Kawatsu L; Uchimura K; Izumi K; Ohkado A; Yoshiyama T BMC Infect Dis; 2018 Aug; 18(1):445. PubMed ID: 30170549 [TBL] [Abstract][Full Text] [Related]
16. Multi-drug resistant tuberculosis burden and risk factors: an update. Marahatta SB Kathmandu Univ Med J (KUMJ); 2010; 8(29):116-25. PubMed ID: 21209520 [TBL] [Abstract][Full Text] [Related]
17. Comparison of the socio-demographic and clinical features of pulmonary TB patients infected with sub-lineages within the W-Beijing and non-Beijing Mycobacterium tuberculosis. Hu Y; Mathema B; Zhao Q; Zheng X; Li D; Jiang W; Wang W; Xu B Tuberculosis (Edinb); 2016 Mar; 97():18-25. PubMed ID: 26980491 [TBL] [Abstract][Full Text] [Related]
18. Clinical management of adults and children with multidrug-resistant and extensively drug-resistant tuberculosis. Dheda K; Chang KC; Guglielmetti L; Furin J; Schaaf HS; Chesov D; Esmail A; Lange C Clin Microbiol Infect; 2017 Mar; 23(3):131-140. PubMed ID: 27756712 [TBL] [Abstract][Full Text] [Related]
19. Strategies for halting the rise of multidrug resistant TB epidemics: assessing the effect of early case detection and isolation. Espindola AL; Varughese M; Laskowski M; Shoukat A; Heffernan JM; Moghadas SM Int Health; 2017 Mar; 9(2):80-90. PubMed ID: 28338827 [TBL] [Abstract][Full Text] [Related]